Drug-loaded lipid-core micelles in mucoadhesive films as a novel dosage form for buccal administration of poorly water-soluble and biological drugs
Author
dc.contributor.author
Chou, Wai-Houng
Author
dc.contributor.author
Galaz, Ariel
Author
dc.contributor.author
Jara, Miguel O.
Author
dc.contributor.author
Gamboa, Alexander
Author
dc.contributor.author
Morales Montecinos, Javier
Admission date
dc.date.accessioned
2021-06-30T00:04:36Z
Available date
dc.date.available
2021-06-30T00:04:36Z
Publication date
dc.date.issued
2020
Cita de ítem
dc.identifier.citation
Pharmaceutics 2020, 12, 1168
es_ES
Identifier
dc.identifier.other
10.3390/pharmaceutics12121168
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/180327
Abstract
dc.description.abstract
The aim of the study was to develop a novel buccal dosage form to transport rhodamine 123 and human insulin as models for poorly water-soluble and biological drugs, using lipid-core micelles (LCMs)-loaded mucoadhesive films. LCMs were synthesized by a low-energy hot emulsification process, yielding spherically shaped, small-sized, monodispersed and negatively charged carriers with high entrapment efficiency. In vitro release studies demonstrated a higher release of insulin rather than rhodamine from LCMs in simulated physiological conditions, due to an initial burst release effect; however, both release profiles are mainly explained by a diffusion mechanism. Furthermore, LCMs-loaded mucoadhesive films were manufactured and preserved with similar mechanical properties and optimal mucoadhesive behavior compared to nonloaded films. Ex vivo permeation experiments using excised porcine buccal epithelium reveal that both rhodamine and insulin-loaded LCM films elicited a significantly enhanced permeation effect compared to LCMs in suspension and free drugs in solution as controls. Hence, LCMs-loaded mucoadhesive films are suitable as buccal dosage form for the transport and delivery of rhodamine 123 and insulin, as models for poorly water-soluble and biological drugs, respectively.
es_ES
Patrocinador
dc.description.sponsorship
Regular FONDECYT Project - Chilean National Agency for Research and Development (ANID)
1181689
PIA/ANID - Chilean National Agency for Research and Development (ANID)
ACT192144
PCI project - Chilean National Agency for Research and Development (ANID)
REDI170653
FONDAP Project - Chilean National Agency for Research and Development (ANID)
15130011
National Doctoral Scholarships - Chilean National Agency for Research and Development (ANID)
21170322
21201798
Equal Opportunities Fulbright-CONICYT Scholarship - Chilean National Agency for Research and Development (ANID)
56170009